Oloker Therapeutics S.r.l

A biotechnology company dedicated to developing cellular therapies for cardiovascular diseases, utilizing its proprietary CPCPlus technology for cardiac cell manufacturing.

Get these signals delivered weekly

Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.